Table 1 Demographic and clinical data of the study population (n = 100)

Age (years)

Median (IQR)

7(4-11.2)

7(4-11.2)

7(4-11.2)

Range

0.5–39 years

0.5–43 years

0.5–43

0.9^a

Gender

Male

23(46%)

31(62%)

54 (54%)

0.1^b

Female

27(54%)

19 (38%)

46 (46%)

Residence

Urban

6(12%)

3 (6%)

9(9%)

0.29^b

Rural

44(88%)

47 (94%)

91(91%)

Abroug’s grading

1

6(12%)

4(8%)

10 (10%)

0.18^b

2

19(38%)

12(24%)

31(31%)

3

25 (50%)

34(68%)

59(59%)

Poisoning severity score at presentation

1

5(10%)

3(6%)

8 (8%)

0.5^b

2

19(38%)

14(28%)

33(33%)

3

22 (44%)

26 (52%)

48(48%)

4

4 (8)

7(14%)

11(11%)

GCS at presentation

Median (IQR)

14(12–15)

13(8–15)

14(9–15)

0.1^a

Range

3–15

3–15

3–15

Systolic pressure at presentation

Median (IQR)

100(83.7-112.5)

90(80–100)

100(80–110)

0.005*^a

Range

80–150

55–120

50–150

Diastolic pressure at presentation

Median (IQR)

70(50-72.5)

60(50–60)

60(50–70)

0.001*^a

Range

40–100

20–80

20–100

Heart rate at presentation

Median (IQR)

120(100–140)

130(120-152.5)

130(110–140)

0.001*^a

Range

60–180

90–235

60–235

Respiratory rate at presentation

Median (IQR)

22(20-26.2)

25(19.7–30)

23(20–30)

0.4^a

Range

7–80

7–50

7–80

Troponin level

Median (IQR)

1(0.2-3)

2(0.1–7.2)

1.8(0.1–5.3)

0.2^a

Range

0–25

0-3000

0-3000

Clinical manifestations

Vomiting

41/50(82%)

32/50(64%)

73/100(73%)

0.07

Pain

25/50 (50%)

21/50(42%)

46/50 (46%)

0.5

Priapism

8/50(16%)

7/50(14%)

15/100(15%)

0.77

Fever

9/50 (18%)

5/50(10%)

14/100(14%)

0.3

Shock

3/50(6%)

9/50(18%)

12/100(12%)

0.1

Site of admission

Inpatient

ICU

28(56%)

22(44%)

20(40%)

30(60%)

48(48%)

52(52%)

0.1^b